Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dynavax Technologies Corp...

    NASDAQ: DVAX · Real-Time Price · USD
    10.18
    -0.09 (-0.88%)
    At close: Jun 16, 2025, 3:59 PM
    9.81
    -3.63%
    Pre-market: Jun 17, 2025, 08:32 AM EDT

    Dynavax Statistics

    Share Statistics

    Dynavax has 120.08M shares outstanding. The number of shares has increased by -5.21% in one year.

    Shares Outstanding

    n/a
    		 120.08M

    Shares Change (YoY)

    n/a
    		 -5.21%

    Shares Change (QoQ)

    n/a
    		 -5.62%

    Owned by Institutions (%)

    n/a
    		 99.56%

    Shares Floating

    n/a
    		 114.49M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,186

    FTD / Avg. Volume

    n/a
    		 0.18%

    Short Selling Information

    The latest short interest is 15.8M, so 13.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.8M

    Short % of Shares Out

    n/a
    		 13.16%

    Short % of Float

    n/a
    		 19.58%

    Short Ratio (days to cover)

    n/a
    		 8.68

    Valuation Ratios

    The PE ratio is 60.81 and the forward PE ratio is 19.35. Dynavax's PEG ratio is -0.12.

    PE Ratio

    n/a
    		 60.81

    Forward PE

    n/a
    		 19.35

    PS Ratio

    n/a
    		 5.99

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 2.78

    P/FCF Ratio

    n/a
    		 27.6

    PEG Ratio

    n/a
    		 -0.12
    Financial Ratio History

    Enterprise Valuation

    Dynavax has an Enterprise Value (EV) of 1.82B.

    EV / Sales

    n/a
    		 6.56

    EV / EBITDA

    n/a
    		 39.81

    EV / EBIT

    n/a
    		 27.35

    EV / FCF

    n/a
    		 30.24

    Financial Position

    The company has a current ratio of 10.8, with a Debt / Equity ratio of 0.43.

    Current Ratio

    n/a
    		 10.8

    Quick Ratio

    n/a
    		 9.91

    Debt / Equity

    n/a
    		 0.43

    Debt / EBITDA

    n/a
    		 5.57

    Debt / FCF

    n/a
    		 4.23

    Interest Coverage

    n/a
    		 -0.61

    Financial Efficiency

    Return on Equity is 4.58% and Return on Invested Capital is -0.4%.

    Return on Equity

    n/a
    		 4.58%

    Return on Assets

    n/a
    		 2.77%

    Return on Invested Capital

    n/a
    		 -0.4%

    Revenue Per Employee

    n/a
    		 $684,558.02

    Profits Per Employee

    n/a
    		 $67,429.63

    Employee Count

    n/a
    		 405

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 0.71

    Taxes

    Income Tax

    n/a
    		 3.55M

    Effective Tax Rate

    n/a
    		 11.49%

    Stock Price Statistics

    The stock price has increased by -10.23% in the last 52 weeks. The beta is 1.04, so Dynavax's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.04

    52-Week Price Change

    n/a
    		 -10.23%

    50-Day Moving Average

    n/a
    		 10.51

    200-Day Moving Average

    n/a
    		 11.93

    Relative Strength Index (RSI)

    n/a
    		 48.79

    Average Volume (20 Days)

    n/a
    		 2,275,771

    Income Statement

    In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.

    Revenue

    n/a
    		 277.25M

    Gross Profit

    n/a
    		 227.8M

    Operating Income

    n/a
    		 -4.12M

    Net Income

    n/a
    		 27.31M

    EBITDA

    n/a
    		 45.7M

    EBIT

    n/a
    		 37.65M

    Earnings Per Share (EPS)

    n/a
    		 0.21
    Full Income Statement

    Balance Sheet

    The company has 95.88M in cash and 254.42M in debt, giving a net cash position of -158.53M.

    Cash & Cash Equivalents

    n/a
    		 95.88M

    Total Debt

    n/a
    		 254.42M

    Net Cash

    n/a
    		 -158.53M

    Retained Earnings

    n/a
    		 -903.27M

    Total Assets

    n/a
    		 945.93M

    Working Capital

    n/a
    		 747.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 66.51M and capital expenditures -6.35M, giving a free cash flow of 60.16M.

    Operating Cash Flow

    n/a
    		 66.51M

    Capital Expenditures

    n/a
    		 -6.35M

    Free Cash Flow

    n/a
    		 60.16M

    FCF Per Share

    n/a
    		 0.46
    Full Cash Flow Statement

    Margins

    Gross margin is 82.17%, with operating and profit margins of -1.49% and 9.85%.

    Gross Margin

    n/a
    		 82.17%

    Operating Margin

    n/a
    		 -1.49%

    Pretax Margin

    n/a
    		 11.13%

    Profit Margin

    n/a
    		 9.85%

    EBITDA Margin

    n/a
    		 16.48%

    EBIT Margin

    n/a
    		 -1.49%

    FCF Margin

    n/a
    		 21.7%

    Dividends & Yields

    DVAX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.64%

    FCF Yield

    n/a
    		 3.62%
    Dividend Details

    Analyst Forecast

    The average price target for DVAX is $31, which is 204.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $31

    Price Target Difference

    n/a
    		 204.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 4.66

    Graham Upside

    n/a
    		 -54.22%

    Stock Splits

    The last stock split was on Nov 10, 2014. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Nov 10, 2014

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 1.22

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist